GlassScriptPhysician profile
Nauman Khalid
NPI 1821336405
$31,486.36
in general payments reported to CMS, 2019-2025
42 companies · $3,391 in 2025
The $3,391 reported for 2025 was more than what 77% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $575 · 2020: $1,580 · 2021: $1,519 · 2022: $16K · 2023: $3,061 · 2024: $5,078 · 2025: $3,391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,390 · Travel and Lodging: $3,140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,390.02 |
| Travel and Lodging | $3,140.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $14,429.72 | 2021-2025 | Corevalve Evolut R, In.Pact Admiral, Avalus |
| Abbott Laboratories | $4,237.85 | 2019-2025 | Aveir, Mitraclip, Amplatzer Amulet |
| Abiomed | $3,003.84 | 2022-2025 | Impella |
| Medtronic Vascular, INC. | $1,834.37 | 2019-2020 | |
| Inari Medical, INC. | $1,231.85 | 2022-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $924.00 | 2021-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $628.41 | 2022-2025 | |
| Amgen INC. | $480.97 | 2021-2025 | Repatha, Repatha |
| Actelion Pharmaceuticals US, INC. | $423.98 | 2021-2025 | Opsumit |
| Janssen Pharmaceuticals, INC | $407.43 | 2021-2024 | Xarelto |
| Atricure, INC. | $367.17 | 2024-2025 | Atriclip Laa Exclusion System, Synergy Ablation System, Atricure Cryoice Cryosphere Cryoablation System |
| Pfizer INC. | $313.17 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $299.98 | 2024-2025 | Sternalock Blu System, A&E Medical / Rotating Surgical Punches, Myo/Wire |
| Shockwave Medical, INC | $289.03 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $288.48 | 2021-2025 | Jardiance |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $255.56 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $199.92 | 2021-2022 | |
| Boston Scientific Corporation | $198.36 | 2020-2022 | |
| Stryker Corporation | $178.27 | 2025 | Artix Mt, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Merck Sharp & Dohme LLC | $172.75 | 2021-2025 | Verquvo |
| Sanofi-Aventis U.S. LLC | $165.83 | 2021-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $151.70 | 2021-2024 | |
| Cvrx, INC. | $150.81 | 2025 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $123.09 | 2021-2025 | Camzyos, Eliquis |
| Lexicon Pharmaceuticals, INC. | $87.86 | 2023-2024 | Inpefa |
| Irhythm Technologies, INC. | $77.70 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Amarin Pharma, INC. | $72.34 | 2021 | |
| Scpharmaceuticals INC. | $69.16 | 2025 | |
| Depuy Synthes Sales INC. | $63.42 | 2025 | Matrixrib |
| Edwards Lifesciences Corporation | $61.93 | 2021-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Chiesi USA, INC. | $49.58 | 2025 | Kengreal |
| Novo Nordisk INC | $31.02 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Livanova USA, INC. | $28.75 | 2023 | Lifesparc |
| Penumbra, INC. | $27.96 | 2023-2024 | Indigo System, Penumbra System |
| Kiniksa Pharmaceuticals, LTD. | $25.07 | 2023 | Arcalyst |
| Philips North America LLC | $23.59 | 2025 | Lm Undivided |
| Kiniksa Pharmaceuticals International, Plc | $21.21 | 2024 | Arcalyst |
| Itamar Medical INC | $20.02 | 2022 | |
| Terumo Medical Corporation | $19.71 | 2020 | |
| Esperion Therapeutics, INC. | $18.57 | 2023 | Nexletol |
| Endologix LLC | $16.80 | 2025 | Torus Stent Graft System, Endocross Device |
| Cardiovascular Systems INC. | $15.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nauman Khalid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.